AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. KAKEN PHARMACEUTIAL CO., LTD.
  3. Financials
  4. Free cash flow

KAKEN PHARMACEUTIAL CO., LTD.【JP:4521】

Market cap
¥198.9B
P/E ratio
71.3x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndFree cash flow (Million JPY)YoY (%)
Mar 31, 202525,642+3481.28%
Mar 31, 2024716-90.15%
Mar 31, 20237,266-29.80%
Mar 31, 202210,350-16.58%
Mar 31, 202112,407-50.98%
Mar 31, 202025,309+31.67%
Mar 31, 201919,221-3.96%
Mar 31, 201820,014+52.07%
Mar 31, 201713,161-45.03%
Mar 31, 201623,943+87.30%
Mar 31, 201512,783

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)